← Back to Search

Community Partnering for Opioid Use Disorder (RB Trial)

N/A
Recruiting
Led By David Cordva, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

RB Trial Summary

This trial in Michigan is studying how resolving legal issues can help people with opioid-use disorder recover, reunite with family, reduce criminal behavior, and access jobs and housing.

Who is the study for?
This trial is for individuals currently receiving treatment for substance use disorders, specifically those struggling with opioid addiction and related challenges like alcoholism, risky behaviors, criminal activity, and housing insecurity. It's not open to people who aren't in such treatment programs.Check my eligibility
What is being tested?
The study tests if resolving legal issues through an online platform can improve drug treatment outcomes. Participants are randomly assigned to receive legal services or not, which helps determine the impact on family reunification, job access, housing stability, and reduced criminal behavior.See study design
What are the potential side effects?
Since this intervention involves legal assistance rather than medical treatments or drugs, traditional side effects are not applicable. However, participants may experience stress or emotional impacts from dealing with their legal issues.

RB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Case type of justice system involvement
Count of justice system involvement
Frequency of substance misuse
+2 more

RB Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Receives tutorial for free online legal resolution at treatment center
Group II: ControlActive Control1 Intervention
The control group is not provided the experimental intervention.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,796 Previous Clinical Trials
6,377,153 Total Patients Enrolled
U.S. National Science FoundationFED
34 Previous Clinical Trials
8,074 Total Patients Enrolled
David Cordva, PhDPrincipal InvestigatorAssociate Professor

Media Library

Removing Barriers to Recovery Clinical Trial Eligibility Overview. Trial Name: NCT05665179 — N/A
Opioid Use Disorder Research Study Groups: Treatment, Control
Opioid Use Disorder Clinical Trial 2023: Removing Barriers to Recovery Highlights & Side Effects. Trial Name: NCT05665179 — N/A
Removing Barriers to Recovery 2023 Treatment Timeline for Medical Study. Trial Name: NCT05665179 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any new openings in this research endeavor?

"Affirmative, the information on clinicaltrials.gov implies that this research is presently enrolling subjects. This project was first created on December 23rd 2021 and then modified most recently on December 16th 2022. The trial requires a total of 800 participants to be sourced from two distinct locations."

Answered by AI

What is the current participation rate of this experiment?

"Affirmative. Clinicaltrials.gov supports the notion that this clinical trial is actively enrolling patients, as it was initially posted on December 23rd 2021 and updated most recently on December 16th 2022. 800 participants need to be recruited from two distinct medical facilities for study completion."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
What site did they apply to?
Home of New Vision
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
~77 spots leftby Jul 2024